Barclays
PRVA icon

Barclays’s Privia Health PRVA Stock Holding History

Barclays’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
103,469
+12,531
+14% +$290K ﹤0.01% 2198
2026
Q1 		$1.87M Sell
90,938
-163,902
-64% -$3.69M ﹤0.01% 2390
2025
Q4 		$6.04M Buy
254,840
+18,235
+8% +$444K ﹤0.01% 2064
2025
Q3 		$5.89M Sell
236,605
-48,314
-17% -$1.04M ﹤0.01% 2066
2025
Q2 		$6.55M Buy
284,919
+99,322
+54% +$2.3M ﹤0.01% 1889
2025
Q1 		$4.17M Sell
185,597
-34,643
-16% -$805K ﹤0.01% 2057
2024
Q4 		$4.31M Sell
220,240
-3,778
-2% -$74.9K ﹤0.01% 2292
2024
Q3 		$4.08M Buy
224,018
+158,188
+240% +$3.02M ﹤0.01% 2260
2024
Q2 		$1.14M Sell
65,830
-52,988
-45% -$939K ﹤0.01% 2521
2024
Q1 		$2.33M Sell
118,818
-81,184
-41% -$1.71M ﹤0.01% 2446
2023
Q4 		$4.61M Buy
200,002
+130,457
+188% +$2.92M ﹤0.01% 2167
2023
Q3 		$1.6M Buy
69,545
+13,656
+24% +$347K ﹤0.01% 2022
2023
Q2 		$1.46M Sell
55,889
-981
-2% -$25.9K ﹤0.01% 2081
2023
Q1 		$1.57M Buy
56,870
+16,421
+41% +$433K ﹤0.01% 2378
2022
Q4 		$919K Buy
40,449
+9,672
+31% +$269K ﹤0.01% 2879
2022
Q3 		$1.05M Buy
30,777
+20,967
+214% +$775K ﹤0.01% 2195
2022
Q2 		$285K Sell
9,810
-69,140
-88% -$1.76M ﹤0.01% 3229
2022
Q1 		$2.11M Buy
+78,950
New +$1.86M ﹤0.01% 1824

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Barclays's PRVA Position: Q2 2026 in Review

Barclays increased its Privia Health (PRVA) stake by 14% in Q2 2026, buying an estimated $290K and bringing the position to 103,469 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Barclays first reported a position in PRVA in Q1 2022 and has held it in 18 quarters since. The position peaked at $6.55M in Q2 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Barclays held 103,469 shares of Privia Health worth $2.66M as of Q2 2026.
  • Barclays bought 12,531 Privia Health shares in Q2 2026, an estimated $290K.
  • Privia Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2198 holding.
  • Barclays first reported a position in Privia Health in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Privia Health position peaked at $6.55M in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.